Introduction: Despite extensive efficacy date and limited data examining drug related side effects, the patient experience and quality of life data is limited for this patient group
Aim(s): The focus of this research is to explore the patient experience of receiving Sunitinib and Everolimus. It aims to explore the true lived experience of receiving molecular targeted agents
Materials and methods: A Qualitative approach was adopted using Phenomenological enquiry, interviews
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Medical treatment - Targeted therapies
Presenting Author: Elizabeth Quaglia
To read results and conclusion, please login ...
Further abstracts you may be interested in